Senaparib

From WikiMD.com - Food, Medicine & Wellness Encyclopedia

Overview of the drug Senaparib


Senaparib
[[File:
Error creating thumbnail:
Chemical structure of Senaparib
|frameless|220px|alt=|]]
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG


Senaparib is a PARP inhibitor that is being investigated for its potential use in the treatment of various types of cancer. It is a small molecule that targets the poly (ADP-ribose) polymerase (PARP) enzyme, which plays a critical role in the repair of DNA damage in cells. By inhibiting this enzyme, Senaparib can enhance the effects of DNA-damaging agents and promote cancer cell death.

Mechanism of Action[edit | edit source]

Senaparib works by inhibiting the activity of the PARP enzyme. PARP is involved in the repair of single-strand breaks in DNA. When PARP is inhibited, these single-strand breaks can accumulate and lead to double-strand breaks, which are more lethal to cells. In cancer cells that are deficient in homologous recombination repair, such as those with BRCA1 or BRCA2 mutations, the accumulation of DNA damage can lead to cell death. This makes Senaparib particularly effective in treating cancers with these genetic deficiencies.

Clinical Development[edit | edit source]

Senaparib is currently undergoing clinical trials to evaluate its efficacy and safety in various cancer types. It is being studied both as a monotherapy and in combination with other anticancer agents. The trials aim to determine the optimal dosing regimen and to identify patient populations that may benefit the most from Senaparib treatment.

Potential Indications[edit | edit source]

Senaparib is being investigated for use in several types of cancer, including:

These cancers are often associated with defects in DNA repair pathways, making them suitable targets for PARP inhibition.

Side Effects[edit | edit source]

As with other PARP inhibitors, Senaparib may cause a range of side effects. Common side effects include:

Patients receiving Senaparib are monitored for these side effects, and dose adjustments may be necessary to manage them.

Research and Development[edit | edit source]

The development of Senaparib is part of a broader effort to create targeted therapies that exploit specific vulnerabilities in cancer cells. By focusing on the DNA repair pathways, researchers hope to develop treatments that are more effective and have fewer side effects than traditional chemotherapy.

Related Pages[edit | edit source]

WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD